Skip to content
PoliticalRepoPoliticalRepo

Person

Official portrait of Rep. Adams, Alma S. [D-NC-12]

Rep. Adams, Alma S. [D-NC-12]

United States · Official source

Records

2,596 records where Rep. Adams, Alma S. [D-NC-12] is listed as a sponsor, author, or other actor. Search with topics and years

Bill· HRH.R. 8399 (119th)referred

STAR Act

United States · United States Congress · 21 April 2026

Bill· HRH.R. 8317 (119th)referred

Tech to Save Moms Act

United States · United States Congress · 15 April 2026

Bill· HRH.R. 8205 (119th)open

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026

United States · United States Congress · 6 April 2026

Accelerating Access to Critical Therapies for ALS Reauthorization Act of 2026 This bill reauthorizes through FY2031 and revises programs that support research and development of drugs and other therapies to address amyotrophic lateral sclerosis (also known as ALS or Lou Gehrig's disease) and other neurodegenerative diseases. The bill reauthorizes grants from the National Institutes of Health (NIH) for scientific research on investigational drugs to prevent or treat ALS for individuals not otherwise eligible for clinical trials, grants from the Food and Drug Administration (FDA) for research and development of therapies to prevent and treat ALS and other neurodegenerative diseases, and a Public-Private Partnership including the FDA and NIH that supports development and regulatory review of treatments for neurodegenerative diseases.  Also, the NIH, in considering renewal of its grants, must assess available information on the safety and efficacy of the investigational drugs. It must also require grantees to promptly report serious and unexpected adverse events associated with their investigational drugs. Additionally, the FDA must publish a plan describing actions it will take over a five-year period to foster development of safe and effective drugs, and facilitate access to investigational drugs, that treat ALS and other rare neurodegenerative diseases. The FDA must also publish a report describing the actions it has taken under the plan.

Bill· HRH.R. 8074 (119th)referred

Kira Johnson Act

United States · United States Congress · 25 March 2026

Bill· HRH.R. 8055 (119th)referred

Extending WIC for New Moms Act

United States · United States Congress · 24 March 2026

Extending WIC for New Moms Act This bill amends the Special Supplemental Nutrition Program for Women, Infants, and Children (WIC) to extend the eligibility periods for breastfeeding and postpartum women. Specifically, a state program may elect to certify a breastfeeding woman for up to 24 months (currently 1 year) postpartum. The bill also expands the eligibility period for postpartum women to up to 24 months after termination of pregnancy (currently 6 months). The Department of Agriculture must submit a report to Congress evaluating the effect of these changes to the program on (1) maternal and infant health outcomes, (2) breastfeeding rates, and (3) qualitative evaluations of family experiences under WIC. 

Bill· HRH.R. 7973 (119th)referred

Momnibus Act

United States · United States Congress · 18 March 2026

Bill· HRH.R. 7716 (119th)referred

Tariff Free Farming Act

United States · United States Congress · 25 February 2026

Bill· HRH.R. 7562 (119th)referred

Office of Small Farms Establishment Act of 2026

United States · United States Congress · 12 February 2026

Office of Small Farms Establishment Act of 2026 This bill requires the Department of Agriculture (USDA) to establish the Office of Small Farms within the farm production and conservation mission area.  The office must coordinate, review, and implement various programs and activities related to small farms, ranches, and forest operations. Under the bill, a small farm, ranch, or forest operation (1) is less than 180 acres or meets another USDA-determined, acreage-based definition of small; and (2) has an annual gross cash farm income of less than $350,000. Among other things, the activities of the office related to small farms, ranches, and forest operations must include coordinating USDA efforts to improve support for these operators; providing or coordinating technical assistance for these operators for USDA grant, cost-share, and loan programs; and providing grants of not more than $25,000 to these operators directly or through cooperative agreements with other entities for areas including equipment and infrastructure repairs and upgrades, uninsured losses, business planning, and conservation practice adoption. In addition, the Office of Small Farms must designate a small farms coordinator in each state.

Bill· HRH.R. 7531 (119th)referred

Healthy Families Act

United States · United States Congress · 12 February 2026

Bill· HRH.R. 7481 (119th)referred

Department of Homeland Security Appropriations Act, 2026

United States · United States Congress · 11 February 2026

Department of Homeland Security Appropriations Act, 2026 This bill provides FY2026 appropriations for various agencies and offices within the Department of Homeland Security (DHS), except for U.S. Immigration and Customs Enforcement (ICE), U.S. Customs and Border Protection (CBP), and management and oversight activities of the Office of the Secretary. Specifically, the bill provides appropriations to DHS for  the Federal Protective Service, the Office of Inspector General, the Transportation Security Administration, the U.S. Coast Guard, the U.S. Secret Service, the Cybersecurity and Infrastructure Security Agency, the Federal Emergency Management Agency (FEMA), U.S. Citizenship and Immigration Services, the Federal Law Enforcement Training Centers, and the Science and Technology Directorate. The bill does not provide appropriations for some agencies and activities that have been funded in prior DHS appropriations acts, including ICE, CBP, and management and oversight activities of the Office of the Secretary.

Resolution· HRESH.Res. 1040 (119th)referred

Recognizing the significance of the Greensboro Four sit-in during Black History Month.

United States · United States Congress · 5 February 2026

This resolution recognizes (1) the Greensboro Four for their contributions to the civil rights movement and the significant role they played as a catalyst for the formation of the Student Non-Violent Coordinating Committee, (2) the value of ethnic and racial diversity in the United States, and (3) the continued importance of sit-ins as an effective form of nonviolent resistance. The resolution also encourages states to include information about the Greensboro Four in their educational curriculums.

Bill· HRH.R. 7341 (119th)referred

GRAD Act

United States · United States Congress · 4 February 2026

Bill· HRH.R. 7092 (119th)referred

RAYS Act

United States · United States Congress · 15 January 2026

Bill· HRH.R. 7024 (119th)referred

Hemp Planting Predictability Act

United States · United States Congress · 13 January 2026

Hemp Planting Predictability Act This bill extends by two years the implementation of changes to the regulation of hemp products, which reimpose certain federal controls over some hemp products. Specifically, Congress enacted the FY2026 agriculture appropriations act (P.L. 119-37) on November 12, 2025. Effective November 12, 2026, the act modifies the statutory definition of hemp products that are considered to be lawful. This bill extends the effective date to November 12, 2028. As background, the 2018 farm bill excluded hemp from the Controlled Substances Act definition of marijuana and defined hemp . As a result, hemp and hemp-derived products at or below the 0.3% delta-9 tetrahydrocannabinol (THC, the psychoactive component of marijuana) concentration threshold were no longer regulated as Schedule I controlled substances and registration with the Drug Enforcement Administration was no longer required to cultivate or handle hemp and hemp-derived products. However, hemp remained subject to Department of Agriculture and Food and Drug Administration regulation. The 2025 changes to the definition of hemp, include changing the limit to a total THC concentration of not more than 0.3% on a dry weight basis rather than only delta-9 THC, explicitly including industrial hemp, excluding seeds from a cannabis plant that exceed a certain THC concentration, and excluding various types of hemp-derived cannabinoid products. Cannabinoids refer to unique chemical compounds that are found in hemp and marijuana (e.g., THC) and are known to exhibit a range of psychological and physiological effects.